Peptide COA Certificate of Analysis and how to read it

A vial labeled „≥99 %“ may look convincing, but without documentation, this information remains only a declaration. A peptide certificate of analysis (COA) is a document that links a specific batch of research compound to the measured analytical results. It is not an administrative add-on for the laboratory. It is a practical basis for deciding whether the material is suitable for inclusion in an experimental procedure.

With peptides, even a small deviation in identity, purity, or content can affect the reproducibility of results. Therefore, a COA helps to separate transparently controlled material from a product where it is not possible to verify the origin, analytical method, or the relationship of the document to a specific vial. Correctly reading the certificate is useful both in routine purchasing and in building an internal quality control system.

What is a Peptide Certificate of Analysis COA?

A COA, short for Certificate of Analysis, is a certificate of analysis issued for a specific production or sales batch. It states what material was tested, which analytical methods were used, what results were obtained, and whether the sample met defined specifications.

A distinction should be made between a generic sample COA and a batch-specific document. A sample document may show an approximate representation of the supplier's analysis format, but it does not confirm the parameters of the product you currently have. For real-world control, a COA with a unique batch number that matches the information on the vial or packaging label is particularly valuable.

At the same time, a COA is not an absolute guarantee of suitability for each experiment. It confirms the result of testing a specific sample at a given time and within the scope of the methods specified. It does not automatically say anything about how the material was stored after shipment, how it was handled after delivery, or whether the selected compound is suitable for a specific research model.

First, verify the batch identification

The first step is to compare the product name, lot number, and, if available, the quantity or form of the material. If the COA lists a different lot number than the label, the document cannot be considered evidence for that vial. This is a simple check that is often overlooked when making a quick purchase.

The certificate should also clearly state the basic data on the analyzed product: peptide name, if applicable sequence, molecular formula, molecular weight, date of analysis and identification of the laboratory or responsible entity. The completeness of the data in itself does not replace the analytical results, but shows whether the document is maintained with an adequate level of traceability.

For synthetic peptides, it is important to see the name as the beginning of the control, not the end. The commercial label may not provide complete information about the chemical form. For example, the acetate, trifluoroacetate or other salt, or a specific modification of the molecule, may make a difference. Such details can change the reported sample weight and are essential for interpreting the results.

Why the batch number is crucial

A single product item may exist in multiple batches with slightly different purity, chromatographic retention, or mass spectral results. Quality control therefore does not work on the principle of „this product has had a good certificate before.“ It works on the principle of „this particular batch has an available and appropriate certificate.“.

For workplaces with their own documentation, it makes sense to store the COA along with data on receipt of the shipment, the condition of the packaging, and the subsequent storage conditions. This allows for retrospective verification of which batch was used when repeating the experiment.

HPLC purity: what the percentage really means

HPLC analysis, or high-performance liquid chromatography, is one of the most common methods for assessing peptide purity. The chromatogram separates the components of a sample according to their interaction with the chromatographic system. Ideally, one main peak dominates, corresponding to the target analyte, while minor peaks represent possible impurities or related substances.

If the COA states a declared purity of ≥99 %, this is usually the percentage of the main peak based on the peak area at a specific detection wavelength. This is very useful, but must be read accurately. HPLC area purity is not automatically identical to peptide content in milligrams, absolute chemical purity, or biological activity.

When comparing batches, note whether the certificate states the method, type of chromatography column, detection, retention time, and the chromatogram itself. Not every document needs to contain the same level of methodological detail, but a result without any description of the method is more difficult to evaluate. Visible chromatogram allows one to assess whether the main peak is clearly separated and whether there are significant unidentified signals nearby.

A higher percentage is not the only criterion. For some early research screens, the availability and consistency of the material may be crucial, while for sensitive analytical or cellular models, the characterization requirements may be significantly more stringent. It always depends on the purpose of the experiment and the risk that impurities pose to the interpretation of the data.

Mass spectrometry confirms identity

While HPLC primarily shows chromatographic purity, mass spectrometry helps confirm that the major component has the expected molecular weight. For a peptide, this is a crucial check point. A molecule may produce a major chromatographic peak, but without mass confirmation, it is not possible to say with the same certainty that it is the correct compound.

The COA may state the theoretical or expected mass and the measured value next to it. The ionization mode used, charges and adducts must be taken into account when interpreting. Therefore, the result may not at first glance match a simple number from the catalog. What is relevant is whether the analytical record supports the identity of the declared peptide.

Mass spectrometry has its limitations. It can very well support mass confirmation, but it may not be able to distinguish all possible isomers or structurally related impurities. The combination of HPLC and MS is therefore the practical basis for quality control in research peptides.

Purity, content and form of the material are not the same

The terms purity and content are often confused in everyday communication. Purity expressed by HPLC evaluates the relative presence of the main chromatographic component. Content, on the other hand, answers the question of how much of the active peptide substance is actually present in the material relative to the total weight of the sample.

Lyophilized peptide may contain bound water, counterions, or residues from the manufacturing process. Therefore, even with high chromatographic purity, the nominal weight of the vial may not directly equal the weight of the peptide itself. In research where precise quantification is required, it is useful to know whether the supplier reports peptide content, water content, residual solvents, or other additional parameters.

However, it is unrealistic to expect every COA to include a full panel of tests. The scope of analysis should be appropriate for the material and its intended use. It is essential that the supplier openly states what has been tested, by what method, and what the declared purity value specifically represents.

When a COA is not enough

A certificate is a strong element of trust, not a substitute for an in-house quality system. If an experiment requires specific endotoxin limits, microbiological purity, precise water content, residual solvent control, or sterility, these parameters must be explicitly tested and documented. HPLC and MS do not confirm them by themselves.

The conditions after the certificate is issued are equally important. Peptides can be sensitive to temperature, humidity, light or repeated handling cycles. Therefore, always read the COA together with the recommended storage conditions and the condition of the shipment upon receipt. Batch integrity does not end with the issuance of the analytical report.

This framework is particularly clear for products intended for scientific purposes only. Quality documentation supports laboratory decision-making and traceability, but does not convert an investigational compound into a drug, dietary supplement, or material intended for human or animal consumption.

How to access COA before ordering

Before including a new supplier or batch in your research, it is worth asking yourself a few factual questions. Is the COA available upon request? Does the batch number match the label? Does it include the HPLC result, chromatogram, and confirmation of identity by MS? Is it clear what the claimed purity means? And is storage and handling information available?

For selected products, DoktorPeptid communicates a declared purity of at least 99 %, HPLC analysis, and the option to request a batch analysis protocol. For the researcher, it is best to view this data as the beginning of a transparent process: request documentation, verify batch compliance, and include it in their own records before using the material in vitro.

A good COA does not appear trustworthy because it is full of complex abbreviations. It is trustworthy when it can be easily linked to a specific vial, the results have a clear analytical basis, and the laboratory knows exactly what the document confirms and what remains to be verified by its own procedures.

Related products

Produkty, ktorých sa táto téma týka: Baktériostatická voda – skladom na Slovensku. Ceny a dostupnosť nájdete v sekcii všetky produkty, doplnky ako dávkovacie perá a zvýhodnené balíčky sú v samostatných kategóriách.

Všetky produkty sú určené výhradne na laboratórny výskum.